Search
31/12/2025
Determinants of treatment decisions in advanced dementia: a protocol for a cross-cultural mixed-methods study
Lima, JP, Mbuagbaw, L, Prasad, M, Kumar, A, Wafeu, GS, Bonnet, R, Agoritsas, T, Li, SY, Liu, ZM, Alonso-Coello, P, Nishijuka, FA, Mirza, R, Silva, CM, Alshanketi, R, Alsahafi, I, Alnuaimi, A, Heen, AF, Schwartz, L, Guyatt, G. Determinants of treatment decisions in advanced dementia: a protocol for a cross-cultural mixed-methods study. BMJ Open. 2025; 15(12)DOI:10.1136/bmjopen-2025-105188. PMID:41475825. IF:2.300(Q2/3D).
31/12/2025
Genomic characterization of invasive Neisseria meningitidis in Spain (2011/12-2022/23): expansion of clonal complex 213 and the potential threat to 4CMenB vaccine strain coverage
Roca-Grande, J, Mir-Cros, A, Muñoz-Almagro, C, Lung, MY, Bellés-Bellés, A, Càmara, J, Cercenado, E, Galán-Ladero, MA, Martín-Nalda, A, Moreno-Mingorance, A, de la Cruz, DN, Orellana, MA, Palop, B, Pérez-Argüello, A, Puigsech-Boixeda, G, Quesada, MD, Rivera, A, Rodriguez-Fernandez, A, de Gopegui, ER, Sarvisé, C, Soler-Garcia, A, Viñado, B, Larrosa, N, González-López, JJ. Genomic characterization of invasive Neisseria meningitidis in Spain (2011/12-2022/23): expansion of clonal complex 213 and the potential threat to 4CMenB vaccine strain coverage. Emerging Microbes & Infections. 2025; 14(1)DOI:10.1080/22221751.2025.2482696. PMID:40105365. IF:7.500(Q1/1D).
31/12/2025
Cost-effectiveness of a machine learning risk prediction model (LungFlag) in the selection of high-risk individuals for non-small cell lung cancer screening in Spain
Trujillo, JC, Soriano, JB, Marzo, M, Higuera, O, Gorospe, L, Pajares, V, Olmedo, ME, Arrabal, N, Flores, A, García, JF, Crespo, M, Carcedo, D, Heuser, C, Obradovic, MMS, Olghi, N, Choman, EN, Seijo, LM. Cost-effectiveness of a machine learning risk prediction model (LungFlag) in the selection of high-risk individuals for non-small cell lung cancer screening in Spain. JOURNAL OF MEDICAL ECONOMICS. 2025; 28(1)DOI:10.1080/13696998.2024.2444781. PMID:39697091. IF:3.000(Q1/2D).
31/12/2025
Peripheral memory B cell population maintenance and long-term survival after perioperative chemoimmunotherapy in NSCLC (NADIM trial)
Rodero, BS, Martínez-Toledo, C, Nadal, E, Molina-Alejandre, M, Campelo, RG, Gil-González, A, Massuti, B, García-Grande, A, Dómine, M, Insa, A, Carpeño, JD, Vence, GH, Majem, M, Martinez-Marti, A, Megias, D, Lobato, D, Collazo-Lorduy, A, Calvo, V, Provencio, M, Cruz-Bermúdez, A. Peripheral memory B cell population maintenance and long-term survival after perioperative chemoimmunotherapy in NSCLC (NADIM trial). OncoImmunology. 2025; 14(1)DOI:10.1080/2162402X.2025.2513109. PMID:40468805. IF:6.300(Q1/2D).